Seven Springs Wealth Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Sell
2,664
-163
-6% -$21.5K 0.07% 68
2026
Q1
$394K Hold
2,827
0.09% 59
2025
Q4
$347K Hold
2,827
0.1% 65
2025
Q3
$314K Sell
2,827
-269
-9% -$30.6K 0.08% 66
2025
Q2
$343K Sell
3,096
-266
-8% -$28.3K 0.09% 64
2025
Q1
$377K Buy
3,362
+546
+19% +$56.3K 0.13% 54
2024
Q4
$260K Buy
2,816
+152
+6% +$13.7K 0.1% 67
2024
Q3
$223K Buy
+2,664
New +$203K 0.08% 67
2024
Q1
Sell
-2,664
Closed -$216K 63
2023
Q4
$216K Buy
+2,664
New +$207K 0.1% 59
2023
Q3
Sell
-2,664
Closed -$205K 57
2023
Q2
$205K Hold
2,664
0.1% 60
2023
Q1
$221K Hold
2,664
0.11% 59
2022
Q4
$229K Sell
2,664
-778
-23% -$61.6K 0.11% 52
2022
Q3
$212K Buy
+3,442
New +$217K 0.12% 56
2021
Q2
Sell
-2,664
Closed -$172K 101
2021
Q1
$172K Hold
2,664
0.08% 58
2020
Q4
$155K Hold
2,664
0.08% 57
2020
Q3
$168K Hold
2,664
0.11% 52
2020
Q2
$205K Sell
2,664
-350
-12% -$26.8K 0.13% 44
2020
Q1
$225K Hold
3,014
0.16% 45
2019
Q4
$196K Buy
+3,014
New +$196K 0.13% 51

Other funds holding GILD

Seven Springs Wealth Group's GILD Position: Q2 2026 in Review

Seven Springs Wealth Group reduced its Gilead Sciences (GILD) stake by 5.8% in Q2 2026, selling an estimated $21.5K and leaving 2,664 shares worth $337K. The position accounts for 0.07% of the portfolio, ranked #68.

Seven Springs Wealth Group first reported a position in GILD in Q4 2019 and has held it in 19 quarters since. The position peaked at $394K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Seven Springs Wealth Group held 2,664 shares of Gilead Sciences worth $337K as of Q2 2026.
  • Seven Springs Wealth Group sold 163 Gilead Sciences shares in Q2 2026, an estimated $21.5K.
  • Gilead Sciences made up 0.07% of Seven Springs Wealth Group's portfolio in Q2 2026, its #68 holding.
  • Seven Springs Wealth Group first reported a position in Gilead Sciences in Q4 2019 and has held it in 19 quarters since.
  • Seven Springs Wealth Group's Gilead Sciences position peaked at $394K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Seven Springs Wealth Group's 13F filing for Q2 2026, filed 4 Aug 2026.